ER-Negative Primary Breast Cancer Linked to Higher Risk of Second Breast Cancer
Patients with ER-negative primary breast cancer may have a higher risk of second breast cancer, but that risk appears to be time-dependent.
All articles by Waseem Qureshi
Global Cost of Cancers Projected to Exceed $25 Trillion
From 2020 to 2050, the global economic cost of cancers is projected to be $25.2 trillion in international dollars.
Oncologists Report Negative Impact of Releasing Clinical Info to Patients Immediately
Most oncology providers surveyed said that immediately releasing clinical information to patients has had a negative impact on their practice and patients.
Biopsychosocial Screening Program Provides Benefits for Cancer Patients
A biopsychosocial screening program can provide clinical benefits for patients with cancer, a study suggests.
Most Quality Metrics for Cancer Screening Tests Are Not Supported by Evidence
Quality metrics for cancer screening tests vary across cancer types, but most metrics are not supported by evidence, a study suggests.
Ide-Cel Bests Standard Care in Relapsed/Refractory Multiple Myeloma
Ide-cel improves outcomes in patients with triple-class-exposed multiple myeloma, when compared with standard care, a phase 3 trial suggests.
APBI Technique as Effective as Whole-Breast Irradiation for Early Breast Cancer
Patients with early-stage breast cancer have similar long-term outcomes with whole-breast irradiation or accelerated partial breast irradiation with multicatheter brachytherapy.
High Pretreatment NLR Signals Worse Outcomes in Muscle-Invasive Bladder Cancer
A high pretreatment neutrophil-to-lymphocyte ratio is associated with worse outcomes in patients with muscle-invasive bladder cancer, a study suggests.
Mirvetuximab Soravtansine Could Be New Standard Care for Platinum-Resistant Ovarian Cancer
Mirvetuximab soravtansine has shown activity in a phase 2 trial of biomarker-selected patients with platinum-resistant ovarian cancer.
At-Home Medication Errors May Be Common for Children With Leukemia, Lymphoma
Medication errors may be common in children with leukemia or lymphoma, and these errors can lead to serious harm, a new study suggests.
- Loading...
Loading...
Next post in Pediatric Cancer
Loading... 
Loading...